These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24047497)

  • 21. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor.
    Ehlert FJ; Griffin MT
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1039-60. PubMed ID: 18305010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligomeric potential of the M2 muscarinic cholinergic receptor.
    Park PS; Wells JW
    J Neurochem; 2004 Aug; 90(3):537-48. PubMed ID: 15255931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
    Avlani V; May LT; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptor.
    Bock A; Mohr K
    Drug Discov Today Technol; 2013; 10(2):e245-52. PubMed ID: 24050275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD; Vaishnav AA; Mash DC
    Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
    Mistry R; Dowling MR; Challiss RA
    Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity.
    Chidiac P; Green MA; Pawagi AB; Wells JW
    Biochemistry; 1997 Jun; 36(24):7361-79. PubMed ID: 9200684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of nematode G protein GOA-1 by the human muscarinic acetylcholine receptor M2 subtype. Functional coupling of G-protein-coupled receptor and G protein originated from evolutionarily distant animals.
    Minaba M; Ichiyama S; Kojima K; Ozaki M; Kato Y
    FEBS J; 2006 Dec; 273(24):5508-16. PubMed ID: 17087737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor.
    Nelson CP; Nahorski SR; Challiss RA
    J Pharmacol Exp Ther; 2006 Jan; 316(1):279-88. PubMed ID: 16188951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail.
    Hayashi MK; Haga T
    Arch Biochem Biophys; 1997 Apr; 340(2):376-82. PubMed ID: 9143344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-Induced Coupling between Oligomers of the M
    Li Y; Shivnaraine RV; Huang F; Wells JW; Gradinaru CC
    Biophys J; 2018 Sep; 115(5):881-895. PubMed ID: 30131171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscarinic receptor: regulation by guanine nucleotides, ions, and N-ethylmaleimide.
    Ehlert FJ; Roeske WR; Yamamura HI
    Fed Proc; 1981 Feb; 40(2):153-9. PubMed ID: 7461140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
    Michal P; Lysíková M; Tucek S
    Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
    Matesic DF; Manning DR; Luthin GR
    Mol Pharmacol; 1991 Sep; 40(3):347-53. PubMed ID: 1716729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.